Assessment Of MRI In Patients With Implanted Cardiac Devices

Arrhythmias, Cardiac Clinical Trial

— MRIPACER  

Official title:

Assessment Of MRI In Patients With Implanted Cardiac Devices

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02815384
• Other study ID #: 1605560370
• Status: Recruiting
• Phase: N/A
• First received: May 26, 2016
• Last updated: October 24, 2017
• Start date: October 12, 2017
• Est. completion date: October 2019

Study information

• Verified date: October 2017
• Source: University of Arizona
• Contact: Bobby Kalb, MD
• Phone: 520-626-9444
• Email: bkalb[@]radiology.arizona.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The research goal is to continue to add to the extensive body of peer-reviewed evidence that demonstrates MRI may be safely performed in patients with cIEDs, after they have been evaluated and cleared by cardiology. This study will allow the researchers to collect data from the facilities ongoing clinical practice regarding the number and types of any adverse clinical reactions, and also to document any changes in the implanted cardiac device that may have occurred during the MRI scan. The researchers will also be assessing the results of the MRI and how the imaging findings impact patient care and the clinical outcome of the patient. This data will then be presented to the FDA and the Centers for Medicare and Medicaid Services to further influence federal guidelines and payment structures.

Description:

Cardiac implantable electronic devices (cIEDs) generally refer to implanted pacemakers and defibrillators for patients with cardiac disorders affecting their heart rhythm. Previously, cIEDs have been regarded as a contraindication to magnetic resonance imaging (MRI) scans, with concerns that the magnetic fields of the MRI may cause problems with the patient's cIED. However, this is a major healthcare issue, as approximately 50-75% of patients with implanted cIEDs are expected to need a future MRI as part of their clinical care. The inability to get such a test may negatively impact the ability to diagnose and treat future diseases.

However, many of the initial concerns regarding the capability of performing MRI in patients with cIED have likely been overstated. There is peer-reviewed literature dating back to the 1990s regarding the ability to safely perform MRI in patients with cIEDs, if certain protocols are followed regarding patient selection and monitoring. In 2011, Nazarian et al from Johns Hopkins University published a study on 438 patients with cIED that received MRI. There were no adverse clinical effects from this study. In fact, the American College of Radiology updated it's guidance document for Safe MR Practices, and cIEDs are no longer listed as a relative contraindication to obtaining an MRI. However, the presence of cIEDs are still regarded as a relative contraindication to performing MRI at some centers. In addition, performance of MRI in the setting of cIED is denied by the Centers for Medicare and Medicaid Services. Continued accrual of data regarding the safety of performing MRI in patients with cIEDs is needed, including outcomes studies that document the clinical impact of improved diagnostics provided by the MRI on patient care.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1500
• Est. completion date: October 2019
• Est. primary completion date: October 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients that require an MRI as part of the normal course of their medical care that also have a cIED and are candidates for MRI .

Exclusion Criteria:

• patient does not require an MRI for their medical care

• patient does not have a cIED

• patient has not been seen or approved by cardiology to be a candidate for MRI

• patients under the age of 18

• pregnant patients

• prisoners

Related Conditions & MeSH terms

• Arrhythmias, Cardiac

Locations

Country	Name	City	State
United States	Banner University Medical Center-Tucson	Tucson	Arizona

Sponsors (1)

Lead Sponsor	Collaborator
University of Arizona

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Safety of MRI, adverse clinical events	collect safety data	immediately post MRI
Secondary	Impact to Patient Care	assess the results of the MRI and how the imaging findings impact patient care	6 months
Secondary	Morbidity, Number of hospitalizations	collected from medical record	6 months
Secondary	Mortality, outcome of death	collected from medical records and phone calls	6 months